FTZ alleviates lipid deposition in diabetic kidney disease by AMPK/ACC/SREBP signaling pathway
Acta Diabetologica · 2025
DOI: 10.1007/s00592-025-02492-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, 2025. Verfasst von Jie Tao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and …. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Acetyl-CoA Carboxylase, AMP-Activated Protein Kinases, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, The Institute of Chinese Medicinal Sciences, Guangdo…
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Tao, J., Zhang, X. Y., Tan, H. B., Huang, M. Y., Yang, Y. Q., & Guo, J. (2025). FTZ alleviates lipid deposition in diabetic kidney disease by AMPK/ACC/SREBP signaling pathway. Acta Diabetologica. https://doi.org/10.1007/s00592-025-02492-5
Vancouver
Tao J, Zhang XY, Tan HB, Huang MY, Yang YQ, Guo J. FTZ alleviates lipid deposition in diabetic kidney disease by AMPK/ACC/SREBP signaling pathway. Acta Diabetologica. 2025. doi:10.1007/s00592-025-02492-5
BibTeX
@article{Tao2025,
author = {Tao, Jie and Zhang, Xiao-Yu and Tan, Hai-Bo and Huang, Min-Yi and Yang, Yi-Qi and Guo, Jiao},
title = {FTZ alleviates lipid deposition in diabetic kidney disease by AMPK/ACC/SREBP signaling pathway},
journal = {Acta Diabetologica},
year = {2025},
doi = {10.1007/s00592-025-02492-5}
}
EUVIMED